Poster Presentation Australian Society for Microbiology Annual Scientific Meeting 2024

CdspoCR_R disruption impairs CdSpoCR-mediated cephamycin resistance in Clostridioides difficile (#25)

Georgia-Rose Gilmore 1 , Sarah Revitt-Mills 1 , Yogitha Srikhanta 1 , Sheena McGowan 1 , Dena Lyras 1
  1. Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria, Australia, 3800

Clostridioides difficile infection (CDI) is associated with significant patient morbidity and mortality worldwide. Recurrent CDI is extremely common due to the ability of C. difficile to form spores, which involves a specific set of proteins called penicillin-binding proteins (PBPs). Cephamycin antibiotics can inhibit C. difficile sporulation by targeting the sporulation-specific PBP, CdSpoVD [1]. Recently, a cephamycin-resistant accessory spore-PBP, CdSpoCR, has been identified in C. difficile. CdspoCR exists in a gene complex alongside genes encoding a putative regulatory signalling system comprised of an antibiotic sensor CdSpoCR_R and a transcriptional repressor CdSpoCR_I. This work aimed to investigate the currently unknown role of this signal transduction system in CdSpoCR expression in C. difficile.

In this study, CdspoCR_R was disrupted in a CdspoCR-positive C. difficile stain. Sporulation assays were then performed using cephamycins to examine changes in sporulation and antibiotic resistance profiles. Following antibiotic exposure, spore counts were high for the wild-type strain, however, no spores were observed for the CdspoCR_R mutant. This result suggests that this putative sensor protein is important for CdSpoCR expression following cephamycin exposure. Additionally, PBP profile analysis and mass spectrometry demonstrated a loss of CdSpoCR in cephamycin-treated CdspoCR_R mutants. These findings further suggest that CdspoCR_R disruption impairs CdSpoCR production and abolishes sporulation in the presence of cephamycins. This study has confirmed a role for CdSpoCR_R in CdSpoCR-mediated cephamycin resistance in C. difficile. Overall, these findings may facilitate the development of anti-sporulation agents capable of reducing spore-mediated transmission and recurrence of CDI.

  1. Srikhanta YN, Hutton ML, Awad MM, et al. Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection. Nat Microbiol. 2019;4(12):2237-45. doi: 10.1038/s41564-019-0519-1.